These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


314 related items for PubMed ID: 14711339

  • 1. Mucosal immunization against respiratory bacterial pathogens.
    Foxwell AR, Kyd JM, Cripps AW.
    Expert Rev Vaccines; 2003 Aug; 2(4):551-60. PubMed ID: 14711339
    [Abstract] [Full Text] [Related]

  • 2. Mucosal vaccination against bacterial respiratory infections.
    Baumann U.
    Expert Rev Vaccines; 2008 Oct; 7(8):1257-76. PubMed ID: 18844598
    [Abstract] [Full Text] [Related]

  • 3. Intranasal vaccines for protection against respiratory and systemic bacterial infections.
    Oliveira ML, Arêas AP, Ho PL.
    Expert Rev Vaccines; 2007 Jun; 6(3):419-29. PubMed ID: 17542756
    [Abstract] [Full Text] [Related]

  • 4. [Oral administration of "Infectvac" for prevention of acute respiratory tract infections].
    Luther P, Brachmann I, Werchan D, Wittig C, Tischner H.
    Z Erkr Atmungsorgane; 1990 Jun; 175(2):95-9. PubMed ID: 2264367
    [Abstract] [Full Text] [Related]

  • 5. Problems and progress towards vaccination against bacterial infections of the respiratory tract.
    Artenstein MS.
    Dev Biol Stand; 1975 Jun; 28():115-25. PubMed ID: 236208
    [Abstract] [Full Text] [Related]

  • 6. [Mucosal immunity with implications for use in developing a new generation of vaccines].
    Osek J, Truszczyński M.
    Postepy Hig Med Dosw; 1995 Jun; 49(4):469-86. PubMed ID: 8657643
    [Abstract] [Full Text] [Related]

  • 7. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
    Hickey DK, Aldwell FE, Beagley KW.
    Vaccine; 2009 Oct 19; 27(44):6217-25. PubMed ID: 19698810
    [Abstract] [Full Text] [Related]

  • 8. Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges.
    Murphy TF.
    Expert Rev Vaccines; 2005 Dec 19; 4(6):843-53. PubMed ID: 16372880
    [Abstract] [Full Text] [Related]

  • 9. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
    Skelding KA, Hickey DK, Horvat JC, Bao S, Roberts KG, Finnie JM, Hansbro PM, Beagley KW.
    Vaccine; 2006 Jan 16; 24(3):355-66. PubMed ID: 16153755
    [Abstract] [Full Text] [Related]

  • 10. Mucosal immunization for bacterial respiratory infections.
    Cripps AW.
    Hum Vaccin; 2008 Jan 16; 4(6):396-9. PubMed ID: 18838872
    [No Abstract] [Full Text] [Related]

  • 11. Oral immunization: an update.
    Mestecky J, Nguyen H, Czerkinsky C, Kiyono H.
    Curr Opin Gastroenterol; 2008 Nov 16; 24(6):713-9. PubMed ID: 19122521
    [Abstract] [Full Text] [Related]

  • 12. Identifying vaccine antigens and assessing delivery systems for the prevention of bacterial infections.
    Kyd J, Cripps A.
    J Biotechnol; 2000 Sep 29; 83(1-2):85-90. PubMed ID: 11000464
    [Abstract] [Full Text] [Related]

  • 13. Vaccines for Moraxella catarrhalis and non-typeable Haemophilus influenzae.
    McMichael JC, Green BA.
    Curr Opin Investig Drugs; 2003 Aug 29; 4(8):953-8. PubMed ID: 14508879
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of resistance among respiratory tract pathogens.
    Jacobs MR, Anon J, Appelbaum PC.
    Clin Lab Med; 2004 Jun 29; 24(2):419-53. PubMed ID: 15177848
    [Abstract] [Full Text] [Related]

  • 15. Prevention of infections of the respiratory tract using the oral application of antigens.
    Tischner H.
    Z Erkr Atmungsorgane; 1991 Jun 29; 176(2-3):131-7. PubMed ID: 1858413
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
    Appelbaum PC.
    Postgrad Med; 2000 Dec 29; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
    [Abstract] [Full Text] [Related]

  • 18. [Assessment of salivary IgA titer in children with recurrent respiratory infections treated with polyvalent oral vaccine. A controlled study].
    Cimadamore N, Agriesti G, Testa A, Borgarello R, Capo G, Crua G.
    Minerva Pediatr; 1988 Jun 29; 40(6):355-60. PubMed ID: 3054472
    [No Abstract] [Full Text] [Related]

  • 19. Respiratory defenses in health and disease.
    Cohn LA, Reinero CR.
    Vet Clin North Am Small Anim Pract; 2007 Sep 29; 37(5):845-60, v. PubMed ID: 17693202
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.